Propofol acts at the sigma-1 receptor and inhibits pentazocine-induced c-Fos expression in the mouse posterior cingulate and retrosplenial cortices

Acta Anaesthesiologica Scandinavica

Volumn 50, Issue 7, 2006, Pages 875-881

  Yamada, M ^a   Nakao, S ^a   Sakamoto, S ^a   Takamori, Y ^a   Tamura, Y ^a   Mochizuki Oda, N ^a   Kataoka, Y ^a   Yamada, H ^a   Shingu, K ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Anesthesia mechanism; c fos expression; Propofol; Sigma 1 receptor

Indexed keywords

ANESTHETIC AGENT; BRADYKININ; DEXMEDETOMIDINE; DROPERIDOL; FURA 2; INTRAFAT; N ALLYLNORMETAZOCINE; OPIATE ANTAGONIST; PENTAZOCINE; PROPOFOL; PROTEIN C FOS; SIGMA 1 OPIATE RECEPTOR; SIGMA 1 OPIATE RECEPTOR ANTAGONIST; THIOPENTAL; TRITIUM; UNCLASSIFIED DRUG;

ANESTHESIA MECHANISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING COMPETITION; BRAIN CORTEX; CALCIUM TRANSPORT; CELL LINE; CINGULATE GYRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; DRUG MECHANISM; DRUG RECEPTOR BINDING; FLUORESCENCE ANALYSIS; INCUBATION TIME; MALE; MOUSE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR INTRINSIC ACTIVITY; STATISTICAL SIGNIFICANCE;

ANALGESICS, OPIOID; ANESTHETICS, INTRAVENOUS; ANIMALS; BRADYKININ; CALCIUM; CELLS, CULTURED; DEXMEDETOMIDINE; DROPERIDOL; GYRUS CINGULI; LIMBIC SYSTEM; MALE; MICE; MICE, INBRED ICR; PENTAZOCINE; PROPOFOL; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTORS, SIGMA; THIOPENTAL;

EID: 33745867663     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2006.01033.x     Document Type: Article

References (31)

1. Guitart X, Codony X, Monroy X. Sigma receptors: biology and therapeutic potential. Psychopharmacology (Berl) 2004; 174: 301-19.
2. Hayashi T, Su T-P. σ-1 receptor ligands. CNS Drugs 2004; 18: 269-84.
3. Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempuer E et al. Purification, molecular cloning, and expression of the mammalian sigmal-binding site. Proc Natl Acad Sci USA 1996; 93: 8072-7.
4. Hayashi T, Su T-P. Regulating ankyrin dynamics: Roles of sigma-1 receptors. Proc Natl Acad Sci USA 2001; 98: 491-6.
5. Su T-P, Hayashi T. Cocaine affects the dynamics of cytoskeletal proteins via sigma 1 receptor. Trends Pharamacol Sci 2001; 22: 456-8.
6. Goyagi T, Bhardwaj A, Koehler RC, Traystman RJ, Hurn PD, Kirsch JR. Potent σ1-recptor ligand 4-phenyl-1-(4-phenylbutyl) piperdine provides ischemic neuroprotection without altering dopamine accumulation in vivo in rats. Anesth Analg 2003; 96: 532-8.
7. Mei J, Pasernak W. σ1 receptor modulation of opioid analgesia in mouse. J Pharmacol Exp Ther 2002; 300: 1070-4.
8. Hudzik TJ, De Costa BR, McMillian DE. Sigma receptor-mediated emetic response in pigeons: agonists, antagonists and modifiers. Eur J Pharmacol 1993; 236: 279-87.
9. Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the 'inert' gas xenon. Br J Anaesth 2002; 89: 739-46.
10. Hustveit O, Maurset A, Øye I. Interaction of the chiral form of ketamine with opioid, phencyclidine, σ and muscarinic receptors. Pharmacol Toxicol 1995; 77: 355-9.
11. Olney JW, Labruyere J, Price MT. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 1989; 244: 1360-2.
12. Hayashi T, Maurice T, Su T-P. Ca2+ signaling via σ1-receptors: novel regulatory mechanism affecting intracellular Ca2+ concentration. J Pharmacol Exp Ther 2000; 293: 788-98.
13. Sharp JW. Phencyclidine (PCP) acts at σ sites to induce c-fos gene expression. Brain Res 1997; 758: 51-8.
14. McCann DJ, Weissman A, Su TP. Sigma-1 and sigma-2 sites in rat brain: Comparison of regional, ontogenetic, and subcellular patterns. Synapse 1994; 17: 182-9.
15. Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-50.
16. Cheng YC, Prusoff WM. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 1973; 22: 3099-108.
17. 3H]-1-[1-(2-Thienyl) Cyclohexyl] Piperidine. J Pharmacol Exp Therp 1986; 238: 739-47.
18. Whittington RA, Virag L, Vulliemoz Y, Couper TB, Morishima HO. Dexmedetomidine increases the cocaine seizure threshold in rats. Anesthesiology 2002; 97: 693-700.
19. Matsumoto RR, Hewett KL, Pouw B, Bowen WD, Husbands SM, Cao IJ, et al. Rimcazole analogs attenuate the convulsive effects of cocaine: Correlation with binding to sigma receptors rather than dopamine transporters. Neuropharmacology 2001; 41: 878-86.
20. Reves JG, Glass PSA, Lubarsky DA. Nonbarbiturate intravenous anesthetics. In: Miller RD, ed. Anesthesia, 5th edn. Philadelphia: Churchill Livingstone Inc., 2000: 256-9.
21. Nishina K, Akamatsu H, Mikawa K, Shiga M, Maekawa N, Obara H. The effects of clonidine and dexmedetomidine on human neutrophil function. Anesth Analg 1999; 88: 452-8.
22. Park KW, Dai HB, Lowenstein E, Stellke FW. Propofol-asoociated dilation of rat distal coronary arteries is mediated by multiple substances, including endothelium-derived nitric oxide. Anesth Analg 1995; 81: 1191-6.
23. Rehberg B, Duch DS. Suppression of central nervous system sodium channel by propofol. Anesthesiology 1999; 91: 512-20.
24. Nishizawa N, Nakao S, Nagata A, Hirase T, Masuzawa M, Shingu K. The effects of ketamine isomers on the mice behavior and c-Fos expression in the posterior cingulated cortex. Brain Res 2000; 857: 188-92.
25. Panegyres PK, Hughes J. Activation of c-fos mRNA in the brain by the k-opioid receptor agonist enadoline and NMDA receptor antagonist dizocilpine. Eur J Pharmacol 1977; 328: 31-6.
26. Cheng SL, Squinto SP, Harlen RE. Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Commun 1988; 157: 698-704.
27. Nakao S, Nagata A, Miyamoto E, Masuzawa M, Murayama T, Shingu K. Inhibitory effect of propofol on ketamine-induced c-Fos expression in the rat posterior cingulate and retrosplenial cortices is mediated by GABAA receptor activation. Acta Anaesthesiol Scand 2003; 47: 284-90.
28. Pain L, Gobaille S, Schleef C, Aunis D, Oberling P. In vivo dopamine measurements in the nucleus accumbens after nonanesthetic and anesthetic doses of propofol in rats. Anesth Analg 2002; 95: 915-9.
29. Nelson NM. Hallucinations after propofol. Anaesthesia 1988; 43: 170.
30. Tramer M, Moore A, McQuary H. Propofol anaesthesia and postoperative nausea and vomiting: quantitative systematic review of randomized controlled studies. Br J Anaesth 1997; 78: 247-55.
31. Jouvert P, Pain L, Aunis D, Zwiller J. The anesthetics propofol and ketamine inhibit cocaine-induced erg-1 gene expression in rat forebrain. Eur J Pharmacol 2002; 449: 239-43.